site stats

Christoph westphal longwood

WebChristoph Westphal. Executive Chair at ImmuneID. Location: Boston, MA. Dr. Westphal is a co-founder and Partner of the Longwood Fund. Dr. Westphal was co-founder, CEO, and lead investor of six biotech companies that have completed IPOs: Momenta, Alnylam, Acceleron Pharmaceuticals, Sirtris (acquired by GSK ), Verastem, and Flex. WebJul 24, 2024 · Editor & Founder Christoph Westphal has closed the fifth in a series of funds for Longwood with $170 million to play with. That’s not a blockbuster by any means in this day and age, but it...

Christoph Westphal - Biography - IMDb

WebChristoph Westphal Expand search. Jobs People Learning ... I will be discussing R&D strategy in a Fireside Chat at the Longwood Healthcare Leaders conference September … WebApr 15, 2024 · TScan was co-founded by Chair Christoph Westphal (Partner, Longwood Fund) based on pioneering research from the Elledge Lab of Harvard Medical School. The Company has raised over $80 million to date from leading strategic collaborators and investors including Longwood Fund, Novartis Institutes for Biomedical Research, … exterior wood white paint https://myagentandrea.com

BSO

WebJul 23, 2024 · The venture creation firm led by serial biotech executive Christoph Westphal has nearly doubled the amount it previously raised for a single fund with its latest pool of capital.. The Longwood ... WebJul 23, 2024 · With the closing of its latest fund, Longwood Fund, which was founded in 2010, has about $475 million across five funds. The company said the $170 million fund … exteris bayer

Longwood Fund-founded TScan Therapeutics files for $100M IPO

Category:SC 13D/A - SEC

Tags:Christoph westphal longwood

Christoph westphal longwood

Flex Pharma, Inc. - sec.gov

WebChristoph Westphal, M.D., Ph.D. Longwood Fund Management. Prudential Tower, Suite 1555. 800 Boylston Street. Boston, Massachusetts 02199 (617) 351-2590 Gunderson ... WebDr. Westphal is co-founder and General Partner of Longwood Fund and has spent 20 years as a biotech CEO, entrepreneur, and investor. Dr. Westphal has been the co … Christoph Westphal was the company’s Co-Founder and startup CEO and …

Christoph westphal longwood

Did you know?

WebChristoph Westphal, Self: 60 Minutes. Christoph Westphal is known for 60 Minutes (1968). Menu. Movies. Release Calendar Top 250 Movies Most Popular Movies Browse … WebOvaScience was co-founded by Richard Aldrich, Michelle Dipp, M.D., Ph.D., and Christoph Westphal M.D., Ph.D., of Longwood Founders Fund, along with fertility expert and Harvard Medical School Professor Jonathan Tilly, Ph.D. of Massachusetts General Hospital, and aging expert and Harvard Medical School Professor David Sinclair, Ph.D. The company ...

WebJul 23, 2024 · Alongside Longwood Fund’s General Partners Christoph Westphal, David Steinberg and Rich Aldrich, and CFO John Lawrence, the Firm has a strong team of … WebFounders Christoph Westphal, Michelle Dipp, Richard Aldrich; Operating Status Active; Also Known As Longwood Partners; Related Hubs Longwood Fund Portfolio Companies; Investor Type Venture Capital Investment Stage Early Stage Venture, Late Stage Venture, Private Equity Number of Exits 16; Contact Email [email protected]; Phone …

WebNov 21, 2024 · Longwood-founded Immunitas also announced key senior management appointments as well as the Board of Directors of the company. ... Dr. Lucio Iannone, Dr. Christoph Westphal, and Dr. Vincent Xiang ... WebChristoph Westphal to move to Longwood Fund, leaving GSK Dr Christoph Westphal, President of SR One, is to leave GlaxoSmithKline later in 2011 to focus on external business interests, primarily the

WebJun 6, 2024 · The Boston-area biotech entrepreneur says he will remain as chairman of Flex Pharma, but as of July 3, he will vacate the CEO role to focus on his venture firm, the Longwood Fund.

WebAug 5, 2024 · Westphal has been the co-founder, CEO, and lead investor of six biotechnology companies that have completed initial public offerings. The relationship … exterity boxWebApr 26, 2024 · TScan was formed in 2024 when Christoph Westphal's venture capital firm, The Longwood Fund, licensed technology from decorated Harvard geneticist Stephen Elledge that uses T-cell receptors ... exterity artiosignWebJul 23, 2024 · Published: Jul 23, 2024 By Alex Keown. Early-stage investment group Longwood Fund closed its fifth fund of approximately $170 million that will be used to support the launch of new companies, as well as the growth of startups in the life sciences space. The opportunity to help create transformative therapies for patients in need is … exterior worlds landscaping \\u0026 designWebMay 2, 2024 · The company is initially operating from the same office as Boston-based Longwood Fund, the venture firm that Westphal co-founded in 2010, according to the filing. exterity playerWebChristoph Westphal, M.D., Ph.D. 2. Check the Appropriate Box if a Member of a Group (See Instructions) ... L.P., Longwood Fund II GP, LLC, Longwood Fund III GP, LLC, Christoph Westphal, M.D., Ph.D., and Richard Aldrich, (collectively, the “Reporting Persons”), pursuant to §240.13d-2(a), to amend the Schedule 13D filed by the Reporting ... exterior wrought iron railing for stairsWebChristoph Westphal was the company’s Co-Founder and startup CEO and Longwood Principal Lea Hachigian was the company’s Co-Founder and startup President. TScan has closed two rounds of financing totaling $48 million from Longwood Fund, Google Ventures, Novartis Venture Fund, Bessemer Venture Partners, 6 Dimensions, and Novartis … exterior wood treatment productsWebJun 23, 2024 · DEM Bio's Board of Directors also gains a cadre of talented executives from the investing firms, including Longwood Fund Founding Partner Christoph Westphal, M.D., Ph.D., Alta Partners Managing Partner Dan Janney, Insight Partners Managing Director Dylan Morris, Pfizer Ventures Principal Marie-Claire Peakman, Ph.D. and … exterior wood window trim repair